Frank Steven 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Frank Steven
Director
Transactions
- Award
Common Stock
2025-05-30$10.75/sh+333$3,580→ 2,199 total
Footnotes (1)
- [F1]Shares of Common Stock issued to the reporting person in lieu of 100% of the prorated quarterly cash Board Member retainer of $3,585.